A PHASE 2A, PLACEBO-CONTROLLED RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF PSILOCYBIN ORAL SOLUTION IN ADULTS WITH GENERALIZED ANXIETY DISORDER

Registry ID

DTI-02A-001

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

DR. CLAUDIO SOARES

Start date

2018-05-25

Last update

2024-01-18

Conditions

• ANXIETY DISORDER

Related clinical trials

• PSILOCYBIN-ASSISTED EXISTENTIAL, ATTACHMENT AND RELATIONAL (PEARL) THERAPY FOR CAREGIVERS OF PATIENTS WITH ADVANCED CANCER: A PHASE II OPEN-LABEL TRIAL
• A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF SERTRALINE VS. PLACEBO IN THE TREATMENT OF ANXIETY IN CHILDREN AND ADOLESCENTS WITH NEURODEVELOPMENTAL DISORDERS
• OPEN LABEL 8-WEEK STUDY OF PRAZOSIN USE IN ADULTS WITH ANXIETY DISORDERS
• A PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY, SAFETY, AND TOLERABILITY OF JNJ-42165279 IN SUBJECTS WITH SOCIAL ANXIETY DISORDER

View on source registry